Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease
Apr 19, 2021
In conventional fluorescence cytometry, each fluorophore in a panel is measured in a target detector, through the use...
Rethinking 3D cell culture with IncuCyte: advanced cell cultures from iPSCs and organoids
Apr 14, 2021
The world is neither flat nor two-dimensional, so why should cell culture be? Traditional cell culture systems grow...
Mar 31, 2021
Cancer cells exhibit metabolic...
Cytek webinar recording : Improved flow cytometry assay resolution with autofluorescence extraction
Mar 30, 2021
The power of autofluorescence extraction in the detection of dim fluorescence on highly autofluorescent cells, and the...
Bruker webinar : High-resolution exploration of ESM-based vascularized tissue-flaps
Mar 22, 2021
By employing a tissue engineering approach based on biological tissue constructs, Dr. Redenski has fabricated composite...
Mar 8, 2021
During this webinar, presented by Riccardo Pasculli, Head of Application Support @ ACCELA, we will cover: technology...
Imaging Flow Cytometry Luminex learning sessions
Mar 5, 2021
Start the new year with new knowledge! Get the most from your Amnis instrument and IDEAS Software with training...
Online courses on Stroke, Diabetes, VCID research
Feb 18, 2021
Are you interested in research of Stroke, Diabetes, or VCID Research? Do you want to share your knowledge with other...
Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
